Kewalramani Reshma Insider Trades

Insider Trading History

Track insider trading activity for Kewalramani Reshma. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $64.6M 137,878 shares
Last Trade
Feb 27, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$19.7M 40,000 shares
$493.48
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $64.8M 138,278 shares
Last Trade
Feb 24, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.42M 4,981 shares
$485.11
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $67.1M 143,259 shares
Last Trade
Feb 17, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.17M 6,554 shares
$483.75
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $70.2M 149,813 shares
Last Trade
Feb 17, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.79M 16,326 shares
$477.40
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $62.5M 133,487 shares
Last Trade
Feb 13, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.36M 13,041 shares
$487.76
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $68.6M 146,528 shares
Last Trade
Feb 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.89M 8,297 shares
$468.41
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $72.5M 154,825 shares
Last Trade
Jan 22, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.2M 38,857 shares
$467.35
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $54.3M 115,968 shares
Last Trade
Aug 06, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$3.9M 10,000 shares
$389.58
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $49.6M 105,915 shares
Last Trade
Feb 26, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.75M 14,079 shares
$479.61
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $56.2M 119,994 shares
Last Trade
Feb 24, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.54M 9,386 shares
$483.28
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $60.6M 129,380 shares
Last Trade
Feb 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.04M 6,553 shares
$463.46
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $63.7M 135,933 shares
Last Trade
Feb 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.62M 19,015 shares
$453.20
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $54.8M 116,918 shares
Last Trade
Feb 10, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.88M 8,300 shares
$467.98
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $35.5M 75,772 shares
Last Trade
Nov 08, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.83M 15,198 shares
$515.00
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $42.6M 90,970 shares
Last Trade
Jul 30, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.68M 15,202 shares
$505.00
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $49.7M 106,172 shares
Last Trade
Jul 22, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.56M 15,202 shares
$497.00
$468.28
Ginkgo Bioworks Holdings
Ginkgo Bioworks Holdings DNA
Director
Holding Value $0 0 shares
Last Trade
Jun 12, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.14M 105,263 shares
$20.30
$8.86
Ginkgo Bioworks Holdings
Ginkgo Bioworks Holdings DNA
Director
Holding Value $1.65M 186,002 shares
Last Trade
Jun 12, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.14M 105,263 shares
$20.30
$8.86
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $56.8M 121,374 shares
Last Trade
May 24, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$715k 1,565 shares
$457.00
$468.28
Vertex Pharmaceuticals
Vertex Pharmaceuticals VRTX
CEO & President
Holding Value $57.6M 122,939 shares
Last Trade
May 24, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$715k 1,565 shares
$456.95
$468.28

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up